Overview

the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This prospective intended to observe the influence of prophylactic and empirical anti-fungal treatment on Severe Sepsis patients with perforations. With the consent of patients' legal guardian for prophylactic use of antifungal agents, patients were divided into two groups: prophylactic group and Empirical group.
Phase:
Phase 2
Details
Lead Sponsor:
Nanjing PLA General Hospital
Treatments:
Caspofungin
Fluconazole